dc.contributor.advisor | Atkins, Gregory | |
dc.contributor.author | Piggott, John M. | |
dc.date.accessioned | 2019-05-01T15:08:45Z | |
dc.date.available | 2019-05-01T15:08:45Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | John M. Piggott, 'Development of SFV-based plasmid electroporation for use in tumour treatment and vaccine delivery', [thesis], Trinity College (Dublin, Ireland). Department of Microbiology, 2008, pp 247 | |
dc.identifier.other | THESIS 8358 | |
dc.description.abstract | Electroporation is the delivery of short and intense electric pulses into living cells
(either in tissue or suspension), which results in a transient and reversible increase in
permeability of the cell transmembrane. This study is designed to develop
electroporation for use as a method of Semliki Forest virus (SFV) - based plasmid
delivery for both tumour treatment and vaccine delivery. | |
dc.format | 1 volume | |
dc.language.iso | en | |
dc.publisher | Trinity College (Dublin, Ireland). Department of Microbiology | |
dc.relation.isversionof | http://stella.catalogue.tcd.ie/iii/encore/record/C__Rb13282113 | |
dc.subject | Microbiology, Ph.D. | |
dc.subject | Ph.D. Trinity College Dublin | |
dc.title | Development of SFV-based plasmid electroporation for use in tumour treatment and vaccine delivery | |
dc.type | thesis | |
dc.type.supercollection | thesis_dissertations | |
dc.type.supercollection | refereed_publications | |
dc.type.qualificationlevel | Doctoral | |
dc.type.qualificationname | Doctor of Philosophy (Ph.D.) | |
dc.rights.ecaccessrights | openAccess | |
dc.format.extentpagination | pp 247 | |
dc.description.note | TARA (Trinity's Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie | |
dc.identifier.uri | http://hdl.handle.net/2262/86585 | |